ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/26/22
ROSEN, A TOP RANKED FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/25/22
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth ConferenceGlobeNewsWire • 03/25/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/24/22
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark™GlobeNewsWire • 03/24/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCPRNewsWire • 03/22/22
ROSEN, A Top Ranked Law Firm, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/21/22
ROSEN, National Trial Lawyers, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/18/22
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/16/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENCPRNewsWire • 03/16/22
ROSEN, A LEADING NATIONAL FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/14/22
FENC Investors Have Opportunity to Lead Fennec Pharmaceuticals Inc. Securities Fraud LawsuitPRNewsWire • 03/14/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/13/22
ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/12/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/09/22
ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCPRNewsWire • 03/08/22
ROSEN, Global Investor Counsel, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 03/08/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCPRNewsWire • 02/28/22
Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business UpdateGlobeNewsWire • 02/28/22
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 02/25/22
ROSEN, Top Ranked Investor Counsel, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 02/24/22
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)Business Wire • 02/22/22
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCNewsfile Corp • 02/20/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENCPRNewsWire • 02/18/22
Kirby McInerney LLP Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors and Encourages Investors to Contact the Firm Before April 11, 2022Business Wire • 02/18/22